Obesity, Inflammation, and Clinical Outcomes in COVID-19: A Multicenter Prospective Cohort Study
CONCLUSION: Obesity is associated with worse outcomes in COVID-19, notably in younger participants and in the pre-Omicron era. Inflammation, as measured by suPAR, is a significant mediator of the association between obesity and COVID-19 outcomes.PMID:38635301 | DOI:10.1210/clinem/dgae273
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Christina G Hutten Kishan Padalia Alexi Vasbinder Yiyuan Huang Anis Ismail Ian Pizzo Kristen Machado Diaz Tonimarie Catalan Feriel Presswalla Elizabeth Anderson Grace Erne Brayden Bitterman Pennelope Blakely Evangelos J Giamarellos-Bourboulis Sven H Loose Source Type: research
More News: Coronavirus | COVID-19 | Eating Disorders & Weight Management | Endocrinology | Obesity | Study | USA Health